Literature DB >> 35848958

Eye Tracking Metrics Differences among Uninjured Adolescents and Those with Acute or Persistent Post-Concussion Symptoms.

Divya Jain, Kristy B Arbogast, Catherine C McDonald, Olivia E Podolak1, Susan S Margulies2, Kristina B Metzger, David R Howell, Mitchell M Scheiman3, Christina L Master.   

Abstract

SIGNIFICANCE: Eye tracking assessments that include pupil metrics can supplement current clinical assessments of vision and autonomic dysfunction in concussed adolescents.
PURPOSE: This study aimed to explore the utility of a 220-second eye tracking assessment in distinguishing eye position, saccadic movement, and pupillary dynamics among uninjured adolescents, those with acute post-concussion symptoms (≤28 days since concussion), or those with persistent post-concussion symptoms (>28 days since concussion).
METHODS: Two hundred fifty-six eye tracking metrics across a prospective observational cohort of 180 uninjured adolescents recruited from a private suburban high school and 224 concussed adolescents, with acute or persistent symptoms, recruited from a tertiary care subspecialty concussion care program, 13 to 17 years old, from August 2017 to June 2021 were compared. Kruskal-Wallis tests were used, and Bonferroni corrections were applied to account for multiple comparisons and constructed receiver operating characteristic curves. Principal components analysis and regression models were applied to determine whether eye tracking metrics can augment clinical and demographic information in differentiating uninjured controls from concussed adolescents.
RESULTS: Two metrics of eye position were worse in those with concussion than uninjured adolescents, and only one metric was significantly different between acute cases and persistent cases. Concussed adolescents had larger left and right mean, median, minimum, and maximum pupil size than uninjured controls. Concussed adolescents had greater differences in mean, median, and variance of left and right pupil size. Twelve metrics distinguished female concussed participants from uninjured; only four were associated with concussion status in males. A logistic regression model including clinical and demographics data and transformed eye tracking metrics performed better in predicting concussion status than clinical and demographics data alone.
CONCLUSIONS: Objective eye tracking technology is capable of quickly identifying vision and pupillary disturbances after concussion, augmenting traditional clinical concussion assessments. These metrics may add to existing clinical practice for monitoring recovery in a heterogeneous adolescent concussion population.
Copyright © 2022 American Academy of Optometry.

Entities:  

Mesh:

Year:  2022        PMID: 35848958      PMCID: PMC9361745          DOI: 10.1097/OPX.0000000000001921

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   2.106


  31 in total

1.  Vision Diagnoses Are Common After Concussion in Adolescents.

Authors:  Christina L Master; Mitchell Scheiman; Michael Gallaway; Arlene Goodman; Roni L Robinson; Stephen R Master; Matthew F Grady
Journal:  Clin Pediatr (Phila)       Date:  2015-07-07       Impact factor: 1.168

2.  Academic effects of concussion in children and adolescents.

Authors:  Danielle M Ransom; Christopher G Vaughan; Lincoln Pratson; Maegan D Sady; Catherine A McGill; Gerard A Gioia
Journal:  Pediatrics       Date:  2015-05-11       Impact factor: 7.124

3.  Factors Affecting Recovery Trajectories in Pediatric Female Concussion.

Authors:  Natasha Desai; Douglas J Wiebe; Daniel J Corwin; Julia E Lockyer; Matthew F Grady; Christina L Master
Journal:  Clin J Sport Med       Date:  2019-09       Impact factor: 3.638

4.  Use of the vestibular and oculomotor examination for concussion in a pediatric emergency department.

Authors:  Daniel J Corwin; Kathleen J Propert; Joseph J Zorc; Mark R Zonfrillo; Douglas J Wiebe
Journal:  Am J Emerg Med       Date:  2018-09-05       Impact factor: 2.469

5.  Eye tracking detects disconjugate eye movements associated with structural traumatic brain injury and concussion.

Authors:  Uzma Samadani; Robert Ritlop; Marleen Reyes; Elena Nehrbass; Meng Li; Elizabeth Lamm; Julia Schneider; David Shimunov; Maria Sava; Radek Kolecki; Paige Burris; Lindsey Altomare; Talha Mehmood; Theodore Smith; Jason H Huang; Christopher McStay; S Rob Todd; Meng Qian; Douglas Kondziolka; Stephen Wall; Paul Huang
Journal:  J Neurotrauma       Date:  2015-02-06       Impact factor: 5.269

6.  Athletic Trainers' Concussion-Assessment and Concussion-Management Practices: An Update.

Authors:  Landon B Lempke; Julianne D Schmidt; Robert C Lynall
Journal:  J Athl Train       Date:  2019-12-19       Impact factor: 2.860

7.  Orthostatic Intolerance and Autonomic Dysfunction in Youth With Persistent Postconcussion Symptoms: A Head-Upright Tilt Table Study.

Authors:  Geoffrey L Heyer; Anastasia Fischer; Julie Wilson; James MacDonald; Sarah Cribbs; Reno Ravindran; Thomas L Pommering; Steven Cuff
Journal:  Clin J Sport Med       Date:  2016-01       Impact factor: 3.638

8.  Reliability of the visio-vestibular examination for concussion among providers in a pediatric emergency department.

Authors:  Daniel J Corwin; Kristy B Arbogast; Casey Swann; Rebecca Haber; Matthew F Grady; Christina L Master
Journal:  Am J Emerg Med       Date:  2020-06-11       Impact factor: 2.469

9.  Frequency of oculomotor disorders in adolescents 11 to 17 years of age with concussion, 4 to 12 weeks post injury.

Authors:  Mitchell Scheiman; Matthew F Grady; Erin Jenewein; Ruth Shoge; Olivia E Podolak; David H Howell; Christina L Master
Journal:  Vision Res       Date:  2021-03-15       Impact factor: 1.886

10.  Sensitivity and specificity of an eye movement tracking-based biomarker for concussion.

Authors:  Uzma Samadani; Meng Li; Meng Qian; Eugene Laska; Robert Ritlop; Radek Kolecki; Marleen Reyes; Lindsey Altomare; Je Yeong Sone; Aylin Adem; Paul Huang; Douglas Kondziolka; Stephen Wall; Spiros Frangos; Charles Marmar
Journal:  Concussion       Date:  2015-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.